SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-22-000057
Filing Date
2022-06-08
Accepted
2022-06-08 07:05:32
Documents
28
Period of Report
2022-06-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20220608.htm   iXBRL 8-K 37893
2 EX-99.1 exhibit99120220608.htm EX-99.1 84142
3 EX-99.2 exhibit992.htm EX-99.2 18655
7 GRAPHIC exhibit992001.jpg GRAPHIC 100068
8 GRAPHIC exhibit992002.jpg GRAPHIC 217416
9 GRAPHIC exhibit992003.jpg GRAPHIC 116839
10 GRAPHIC exhibit992004.jpg GRAPHIC 119871
11 GRAPHIC exhibit992005.jpg GRAPHIC 135169
12 GRAPHIC exhibit992006.jpg GRAPHIC 89659
13 GRAPHIC exhibit992007.jpg GRAPHIC 165416
14 GRAPHIC exhibit992008.jpg GRAPHIC 105263
15 GRAPHIC exhibit992009.jpg GRAPHIC 110253
16 GRAPHIC exhibit992010.jpg GRAPHIC 71815
17 GRAPHIC exhibit992011.jpg GRAPHIC 79083
18 GRAPHIC exhibit992012.jpg GRAPHIC 136334
19 GRAPHIC exhibit992013.jpg GRAPHIC 124726
20 GRAPHIC exhibit992014.jpg GRAPHIC 86266
  Complete submission text file 0001764013-22-000057.txt   2580740

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20220608.xsd EX-101.SCH 1896
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20220608_lab.xml EX-101.LAB 23832
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20220608_pre.xml EX-101.PRE 12504
22 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20220608_htm.xml XML 10819
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 221002552
SIC: 2836 Biological Products, (No Diagnostic Substances)